dihexa cancer risk hgf c met The HGF/c-Met Axis: A Promising Therapeutic Target in Dihexa (PNB-0408) | c-Met/HGFR Activator
Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress Anti cancer therapeutic strategies based on HGF MET, EpCAM, and tumor stromal cross talk Cancer Cell International Springer Nature Link Therapeutic Strategies for Ovarian Cancer in Point of HGF c MET Targeting Frontiers Hepatocyte growth factor mimetic protects lateral line hair cells from aminoglycoside exposure HGF c Met pathway facilitates the perineural invasion of pancreatic cancer by activating the mTOR NGF axis Cell Death & Disease
Pay in 4 interest-free payments of $5.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




